ARTICLE | Company News
Cellectis, genOway deal
January 12, 2009 8:00 AM UTC
Cellectis ended its October 2001 non-exclusive, worldwide license deal with genOway covering the use of homologous recombination for cellular and animal model development. Cellectis alleges that genOw...